Hyamedix ApS
CVR 39177749 · Private limited company (ApS) · Active · Medium risk
Hyamedix ApS is a Private limited company (ApS), founded on , based in Frederiksberg. The company is registered in the industry fremstilling af farmaceutiske råvarer. Our model estimates a bankruptcy risk of 2.6% over the next 12 months, which is 1.9 times the average for Danish companies. 9 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -10.1m and a net result of DKK -887k. CEO: Birgit Fuhlendorff, Khadija Schwach-Abdellaoui.
Bankruptcy risk for Hyamedix ApS
1.9 × the average (1.41%) · higher risk than 86% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39177749
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (8 years)
- Address
- c/o Symbion, Nordre Fasanvej 215
2000 Frederiksberg - Municipality
- Frederiksberg
- Industry
- Fremstilling af farmaceutiske råvarer (211000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 47k
- Employees
- 1 (2018)
- Auditor
- Beierholm Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 9 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -638.4% |
| Current ratio | 96% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 111 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 1.8m | DKK -36k |
| Net profit | DKK -887k | DKK -1.4m |
| Equity | DKK -10.1m | DKK -9.2m |
| Total assets | DKK 1.6m | DKK 2.3m |
| Cash | DKK 266k | – |
| Short-term debt | DKK 1.6m | – |
| Avg. employees | 2 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Beierholm.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 180 | ||
| 1 Jan 2024 – 31 Dec 2024 | 189 | Late | |
| 1 Jan 2023 – 31 Dec 2023 | 180 | ||
| 1 Jan 2022 – 31 Dec 2022 | 181 | ||
| 1 Jan 2021 – 31 Dec 2021 | 175 | ||
| 1 Jan 2020 – 31 Dec 2020 | 116 | ||
| 1 Jan 2019 – 31 Dec 2019 | 112 | ||
| 1 Jan 2018 – 31 Dec 2018 | 151 | ||
| 15 Dec 2017 – 31 Dec 2017 | 170 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Birgit Fuhlendorff | Current | |
| CEO | Khadija Schwach-Abdellaoui | Current | |
| Board | Michael Foldager Johansen | Current | |
| Board | Jesper Ahlmann Funding Andersen | Current | |
| Board | Khadija Schwach-Abdellaoui | Current | |
| Board | Todd Andrew Kenworth | ||
| Board | Timothy James Eviston | ||
| Owner (33%) | Vivida ApS | Current | |
| Owner (5%) | Ginkgo ApS | Current | |
| Owner (5%) | Jafa Holding ApS | Current | |
| Owner (5%) | GoQing Ltd. | Current | |
| Owner (20%) | Ginnerup Capital ApS | Current | |
| Owner (50%) | Todd Andrew Kenworth | ||
| Owner (33%) | Michael Foldager Johansen | ||
| Owner (33%) | Hyaworth ApS | ||
| Owner (5%) | Jesper Ahlmann Funding Andersen | ||
| Owner (33%) | Todd Andrew Kenworth | ||
| Owner (33%) | Michael Foldager Johansen | ||
| Owner (15%) | Ginnerup Capital ApS | ||
| Auditor | Beierholm Godkendt Revisionspartnerselskab | Current | |
| Founder | Vivida ApS | Current | |
| Founder | Hyaworth ApS | Current | |
| Founder | Huang Zhe | Current |
Address history (3 moves)
| c/o Symbion, Nordre Fasanvej 215, 2000 Frederiksberg | |
| c/o Symbion, Fruebjergvej 3, 2100 København Ø | |
| c/o Copenhagen Bioscience Park, Ole Maaløes Vej 3, 2200 København N | |
| Flæsketorvet 68, 1., 1711 København V |
Former names
| Hyamedix ApS | – now |
| Hyamedix IVS | – |
Employees per year
Other companies at the same address
- Nordetect ApS Bankrupt
- ACESION PHARMA ApS Active
- AdaptVac ApS Active
- Adcendo ApS Active
- Akylox Therapeutics ApS Active
- Antraka ApS Opløst
- Augustine Therapeutics Denmark ApS Active
- Autocert ApS Active
- Avancert ApS Active
- B4C ApS Active
- BOOST Pharma ApS Active
- Baekmark IP Consult ApS Active
- Betula Capital ApS Active
- BioPhenyx ApS Active
- Biobridge Partners ApS Active
- Biotinia ApS Active
- CMCAssist ApS Active
- CMCGreenhouse ApS Active
- CMCHoldings ApS Active
- CaMaRa ApS Active
- Catalyst Vaccination A/S Active
- Chris Cording Jønsson Holding ApS Active
- DARERL ApS Active
- DFY ApS Active
- DeltaBot ApS Active
Similar companies in Frederiksberg
- OLIGOMAKER ApS Frederiksberg
- HyAesthetics ApS Frederiksberg
Questions and answers about Hyamedix ApS
Has Hyamedix ApS gone bankrupt?
No, Hyamedix ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Hyamedix ApS?
Our model estimates a bankruptcy risk of 2.6% over the next 12 months (medium risk), which is 1.9 times the average for Danish companies.
Who is the CEO of Hyamedix ApS?
Birgit Fuhlendorff, Khadija Schwach-Abdellaoui are the CEOs of Hyamedix ApS.
Who is the auditor of Hyamedix ApS?
Hyamedix ApS most recently used Beierholm Godkendt Revisionspartnerselskab.
When was Hyamedix ApS founded?
Hyamedix ApS was founded on 15 December 2017.
What is the equity of Hyamedix ApS?
Equity was DKK -10.1m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.